98-30674. Availability of an Environmental Assessment and Finding of No Significant Impact for Field Testing Pseudorabies Vaccine, Modified Live Virus  

  • [Federal Register Volume 63, Number 221 (Tuesday, November 17, 1998)]
    [Notices]
    [Pages 63826-63827]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-30674]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF AGRICULTURE
    
    Animal and Plant Health Inspection Service
    [Docket No. 98-111-1]
    
    
    Availability of an Environmental Assessment and Finding of No 
    Significant Impact for Field Testing Pseudorabies Vaccine, Modified 
    Live Virus
    
    AGENCY: Animal and Plant Health Inspection Service, USDA.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    SUMMARY: We are advising the public that the Animal and Plant Health 
    Inspection Service has prepared an environmental assessment and finding 
    of no significant impact concerning authorization to ship for the 
    purpose of field testing, and then to field test, an unlicensed live 
    viral pseudorabies vaccine for use in swine. A risk analysis, which 
    forms the basis for the environmental assessment, has led us to 
    conclude that field testing this veterinary vaccine will not have a 
    significant impact on the quality of the human environment. Based on 
    our finding of no significant impact, we have determined that an 
    environmental impact statement need not be prepared. We intend to 
    authorize shipment of this vaccine for field testing 14 days after the 
    date of this notice, unless new, substantial issues bearing on the 
    effects of this action are brought to our attention. We also intend to 
    issue a veterinary biological product license for this vaccine, 
    provided the field test data support the conclusions of the 
    environmental assessment and finding of no significant impact and the 
    product meets all other requirements for licensure.
    
    ADDRESSES: Copies of the environmental assessment and finding of no 
    significant impact may be obtained by contacting the person listed 
    under FOR FURTHER INFORMATION CONTACT. Please refer to the docket 
    number, date, and complete title of this notice when requesting copies. 
    Copies of the environmental assessment and finding of no significant 
    impact (as well as the risk analysis with confidential business 
    information removed) are available for public inspection at USDA, room 
    1141, South Building, 14th Street and Independence Avenue SW., 
    Washington, DC, between 8 a.m. and 4:30 p.m., Monday through Friday, 
    except holidays. Persons wishing to inspect those documents are 
    requested to call ahead on (202) 690-2817 to facilitate entry into the 
    reading room.
    
    FOR FURTHER INFORMATION CONTACT: Dr. Jeanette Greenberg, Technical 
    Writer-Editor, Center for Veterinary Biologics, Licensing and Policy 
    Development, VS, APHIS, USDA, 4700 River Road Unit 148, Riverdale, MD 
    20737-1231; telephone (301) 734-5338; fax (301) 734-4314; or e-mail: 
    Jeanette.B.Greenberg@usda.gov.
    
    SUPPLEMENTARY INFORMATION: Under the Virus-Serum-Toxin Act (21 U.S.C. 
    151 et seq.), a veterinary biological product must be shown to be pure, 
    safe, potent, and efficacious before a veterinary biological product 
    license may be issued. A field test is generally necessary to satisfy 
    prelicensing requirements for veterinary biological products. Prior to 
    conducting a field test on an unlicensed product, an applicant must 
    obtain approval from the Animal and Plant Health Inspection Service 
    (APHIS), as well as obtain APHIS' authorization to ship the product for 
    field testing.
        In determining whether to authorize shipment and grant approval for 
    the field testing of the unlicensed product referenced in this notice, 
    APHIS conducted a risk analysis to assess the potential effects of this 
    product on the safety of animals, public health, and the environment. 
    Based on the risk analysis, APHIS has prepared an environmental 
    assessment (EA). APHIS has concluded that field testing the unlicensed 
    veterinary biological product will not significantly affect the quality 
    of the human environment. Based on this finding of no significant 
    impact (FONSI), we have determined that there is no need to prepare an 
    environmental impact statement.
        The EA and FONSI have been prepared by APHIS concerning the field 
    testing of the following unlicensed veterinary biological product:
        Requester: Ambico, Inc.
        Product: Pseudorabies Vaccine, Modified Live Virus
        Field test locations: Iowa, Indiana, and Minnesota.
        The above-mentioned vaccine is for use as an aid in the program to 
    eradicate
    
    [[Page 63827]]
    
    pseudorabies in the U.S. swine population. The vaccine contains live 
    pseudorabies virus with gI and tk gene deletions, which significantly 
    reduce the pathogenicity of the vaccine virus compared with the wild 
    type virus.
        The EA and FONSI have been prepared in accordance with: (1) The 
    National Environmental Policy Act of 1969, as amended (NEPA) (42 U.S.C. 
    4321 et seq.); (2) regulations of the Council on Environmental Quality 
    for implementing the procedural provisions of NEPA (40 CFR parts 1500-
    1508); (3) USDA regulations implementing NEPA (7 CFR part 1b); and (4) 
    APHIS' NEPA Implementing Procedures (7 CFR part 372).
        Unless substantial environmental issues are raised in response to 
    this notice, APHIS intends to authorize shipment of the above product 
    for the initiation of field tests 14 days from the date of this notice.
        Because the issues raised by field testing and by issuance of a 
    license are identical, APHIS has concluded that the EA and FONSI that 
    were generated for field testing would also be applicable to the 
    proposed licensing action. Provided that the field test data support 
    the conclusions of the original EA and FONSI, APHIS does not intend to 
    issue a separate EA to support the issuance of the product license, and 
    would determine that an environmental impact statement need not be 
    prepared. APHIS intends to issue a veterinary biological product 
    license for this vaccine following completion of the field test 
    provided no adverse impacts on the human environment are identified and 
    provided the product meets all other requirements for licensure.
    
        Authority: 21 U.S.C. 151-159.
    
        Done in Washington, DC, this 10th day of November 1998.
    Joan M. Arnoldi,
    Acting Administrator, Animal and Plant Health Inspection Service.
    [FR Doc. 98-30674 Filed 11-16-98; 8:45 am]
    BILLING CODE 3410-34-P
    
    
    

Document Information

Published:
11/17/1998
Department:
Animal and Plant Health Inspection Service
Entry Type:
Notice
Action:
Notice.
Document Number:
98-30674
Pages:
63826-63827 (2 pages)
Docket Numbers:
Docket No. 98-111-1
PDF File:
98-30674.pdf